PTPRC and neoplasm: As shown in Figure 1c, we found a significant increase in the percentages of CD45+ immune cells within the BRAFi‐sensitive tumors in comparison with untreated tumors, however, this was not reflected in absolute numbers per gram of tumor tissue.